[HTML][HTML] The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
Benign prostatic hyperplasia (BPH) is characterized by an enlarged prostate, lower urinary
tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a …
tract symptoms (LUTS), and a decreased urinary flow rate. Common in older men, BPH is a …
Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management
M Emberton, EB Cornel, PF Bassi… - … journal of clinical …, 2008 - Wiley Online Library
Benign prostatic hyperplasia (BPH) is a complex disease that is progressive in many men.
BPH is commonly associated with bothersome lower urinary tract symptoms; progressive …
BPH is commonly associated with bothersome lower urinary tract symptoms; progressive …
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the …
CG Roehrborn, P Siami, J Barkin, R Damião… - European urology, 2010 - Elsevier
BACKGROUND: Combination therapy with dutasteride and tamsulosin provides significantly
greater benefit than either monotherapy for various patient-reported outcomes in men with …
greater benefit than either monotherapy for various patient-reported outcomes in men with …
Prostatic artery embolization as a primary treatment for benign prostatic hyperplasia: preliminary results in two patients
Symptomatic benign prostatic hyperplasia (BPH) typically occurs in the sixth and seventh
decades, and the most frequent obstructive urinary symptoms are hesitancy, decreased …
decades, and the most frequent obstructive urinary symptoms are hesitancy, decreased …
Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia
PURPOSE: To show that prostatic artery embolization (PAE) improves quality of life (QoL)
and lower urinary tract symptoms in patients with acute urinary retention caused by benign …
and lower urinary tract symptoms in patients with acute urinary retention caused by benign …
Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction
P Abrams, S Kaplan, HJ De Koning Gans… - The Journal of …, 2006 - auajournals.org
Purpose: Antimuscarinic therapy for men with OAB and BOO is perceived as a potential risk
for urinary retention. Using pressure flow urodynamics, we evaluated the safety of …
for urinary retention. Using pressure flow urodynamics, we evaluated the safety of …
Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates> 90 g: a prospective single-center study
AM de Assis, AM Moreira… - Journal of Vascular and …, 2015 - Elsevier
Purpose To describe the safety and efficacy of prostatic artery embolization (PAE) with
spherical microparticles to treat lower urinary tract symptoms associated with benign …
spherical microparticles to treat lower urinary tract symptoms associated with benign …
Alpha-blocker therapy can be withdrawn in the majority of men following initial combination therapy with the dual 5α-reductase inhibitor dutasteride
J Barkin, M Guimaraes, G Jacobi, D Pushkar, S Taylor… - European urology, 2003 - Elsevier
Objectives: The Symptom Management After Reducing Therapy (SMART-1) study examined
the combination of the dual action 5α-reductase inhibitor (5ARI) dutasteride, and α1-blocker …
the combination of the dual action 5α-reductase inhibitor (5ARI) dutasteride, and α1-blocker …
Relationship between age and prostate size
SJ Zhang, HN Qian, Y Zhao, K Sun… - Asian journal of …, 2012 - pmc.ncbi.nlm.nih.gov
In a community-based study, the relationship between age and human prostate size was
investigated in a population of men between the ages of 40 and 70 years to determine the …
investigated in a population of men between the ages of 40 and 70 years to determine the …
The detrusor muscle: an innocent victim of bladder outlet obstruction
V Mirone, C Imbimbo, N Longo, F Fusco - European urology, 2007 - Elsevier
OBJECTIVES: Benign prostatic hyperplasia (BPH) is considered a frequent cause of bladder
outlet obstruction (BOO) and lower urinary tract symptoms (LUTS), although the …
outlet obstruction (BOO) and lower urinary tract symptoms (LUTS), although the …